HLA-C and neoplasm: First, a portion of mutated peptide epitopes resulting from either driver or passenger mutations can be presented on tumour cell class I MHC molecules and be recognised by CD8+ T cells, which, together with T-cell-attracting chemokines such as CXCL9 and CXCL10, promotes a brisk infiltration by cytotoxic T lymphocytes.